| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | miRNA binding | 4.09e-05 | 48 | 28 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 8.84e-05 | 62 | 28 | 3 | GO:0061980 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 1.46e-04 | 13 | 28 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 1.71e-04 | 14 | 28 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.79e-04 | 891 | 28 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 6.51e-04 | 27 | 28 | 2 | GO:0015271 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 7.01e-04 | 28 | 28 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.02e-03 | 1189 | 28 | 7 | GO:0046914 | |
| GeneOntologyMolecularFunction | deaminase activity | 1.03e-03 | 34 | 28 | 2 | GO:0019239 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 1.16e-03 | 36 | 28 | 2 | GO:0016814 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 3.62e-03 | 64 | 28 | 2 | GO:0036002 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock by photoperiod | 5.05e-06 | 25 | 28 | 3 | GO:0043153 | |
| GeneOntologyBiologicalProcess | photoperiodism | 7.17e-06 | 28 | 28 | 3 | GO:0009648 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock | 8.88e-06 | 30 | 28 | 3 | GO:0009649 | |
| GeneOntologyBiologicalProcess | negative regulation of translation in response to stress | 2.66e-05 | 6 | 28 | 2 | GO:0032055 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 2.66e-05 | 6 | 28 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 2.66e-05 | 6 | 28 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 3.18e-05 | 135 | 28 | 4 | GO:0042752 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 7.94e-05 | 10 | 28 | 2 | GO:0070383 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.08e-04 | 358 | 28 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.08e-04 | 358 | 28 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.14e-04 | 362 | 28 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 1.16e-04 | 12 | 28 | 2 | GO:0016554 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 1.42e-04 | 75 | 28 | 3 | GO:0032922 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 1.60e-04 | 14 | 28 | 2 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 1.60e-04 | 14 | 28 | 2 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 1.60e-04 | 14 | 28 | 2 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 1.60e-04 | 14 | 28 | 2 | GO:0045006 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 2.11e-04 | 16 | 28 | 2 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 2.11e-04 | 16 | 28 | 2 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 2.11e-04 | 16 | 28 | 2 | GO:0046133 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 2.43e-04 | 90 | 28 | 3 | GO:0050688 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 2.51e-04 | 91 | 28 | 3 | GO:0006446 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 2.51e-04 | 91 | 28 | 3 | GO:0045069 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 2.68e-04 | 18 | 28 | 2 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 3.00e-04 | 19 | 28 | 2 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 3.00e-04 | 19 | 28 | 2 | GO:0016553 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 3.33e-04 | 20 | 28 | 2 | GO:0039692 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 3.33e-04 | 248 | 28 | 4 | GO:0007623 | |
| GeneOntologyBiologicalProcess | optic nerve development | 4.04e-04 | 22 | 28 | 2 | GO:0021554 | |
| GeneOntologyBiologicalProcess | negative regulation of translational initiation | 4.81e-04 | 24 | 28 | 2 | GO:0045947 | |
| GeneOntologyBiologicalProcess | RNA splicing | 5.18e-04 | 502 | 28 | 5 | GO:0008380 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 5.66e-04 | 26 | 28 | 2 | GO:0042454 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 6.11e-04 | 27 | 28 | 2 | GO:0006213 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport into cytosol | 6.11e-04 | 27 | 28 | 2 | GO:0010522 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 6.57e-04 | 28 | 28 | 2 | GO:0048025 | |
| GeneOntologyBiologicalProcess | regulation of translation in response to stress | 6.57e-04 | 28 | 28 | 2 | GO:0043555 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 6.98e-04 | 129 | 28 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 7.05e-04 | 29 | 28 | 2 | GO:0032469 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 7.05e-04 | 29 | 28 | 2 | GO:0050686 | |
| GeneOntologyBiologicalProcess | translational initiation | 7.47e-04 | 132 | 28 | 3 | GO:0006413 | |
| GeneOntologyBiologicalProcess | mRNA processing | 7.89e-04 | 551 | 28 | 5 | GO:0006397 | |
| GeneOntologyBiologicalProcess | DNA modification | 8.06e-04 | 31 | 28 | 2 | GO:0006304 | |
| GeneOntologyBiologicalProcess | viral genome replication | 8.32e-04 | 137 | 28 | 3 | GO:0019079 | |
| GeneOntologyBiologicalProcess | viral RNA genome replication | 8.60e-04 | 32 | 28 | 2 | GO:0039694 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 8.60e-04 | 32 | 28 | 2 | GO:0009164 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 9.14e-04 | 33 | 28 | 2 | GO:0033119 | |
| GeneOntologyBiologicalProcess | corpus callosum development | 9.14e-04 | 33 | 28 | 2 | GO:0022038 | |
| GeneOntologyBiologicalProcess | defense response to virus | 1.11e-03 | 342 | 28 | 4 | GO:0051607 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 1.15e-03 | 37 | 28 | 2 | GO:0034656 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 1.21e-03 | 156 | 28 | 3 | GO:1903900 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.23e-03 | 917 | 28 | 6 | GO:0016071 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.26e-03 | 158 | 28 | 3 | GO:0050684 | |
| GeneOntologyBiologicalProcess | rhythmic process | 1.34e-03 | 360 | 28 | 4 | GO:0048511 | |
| GeneOntologyBiologicalProcess | glycosyl compound catabolic process | 1.41e-03 | 41 | 28 | 2 | GO:1901658 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 1.48e-03 | 42 | 28 | 2 | GO:0060402 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 1.67e-03 | 382 | 28 | 4 | GO:0009416 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 1.77e-03 | 46 | 28 | 2 | GO:0072529 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 1.77e-03 | 46 | 28 | 2 | GO:0010526 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 1.93e-03 | 48 | 28 | 2 | GO:0009119 | |
| GeneOntologyBiologicalProcess | retrotransposition | 1.93e-03 | 48 | 28 | 2 | GO:0032197 | |
| GeneOntologyBiologicalProcess | regulation of viral process | 2.00e-03 | 186 | 28 | 3 | GO:0050792 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.01e-03 | 49 | 28 | 2 | GO:0042771 | |
| GeneOntologyBiologicalProcess | skeletal muscle fiber development | 2.01e-03 | 49 | 28 | 2 | GO:0048741 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 beta production | 2.09e-03 | 50 | 28 | 2 | GO:0032691 | |
| GeneOntologyBiologicalProcess | transposition | 2.09e-03 | 50 | 28 | 2 | GO:0032196 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 2.36e-03 | 197 | 28 | 3 | GO:0002244 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 2.43e-03 | 199 | 28 | 3 | GO:0051147 | |
| GeneOntologyBiologicalProcess | myotube cell development | 2.43e-03 | 54 | 28 | 2 | GO:0014904 | |
| GeneOntologyBiologicalProcess | response to virus | 2.46e-03 | 425 | 28 | 4 | GO:0009615 | |
| GeneOntologyBiologicalProcess | negative regulation of viral genome replication | 2.62e-03 | 56 | 28 | 2 | GO:0045071 | |
| GeneOntologyBiologicalProcess | response to gamma radiation | 2.62e-03 | 56 | 28 | 2 | GO:0010332 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.71e-03 | 207 | 28 | 3 | GO:0043484 | |
| GeneOntologyBiologicalProcess | epithelium development | 2.87e-03 | 1469 | 28 | 7 | GO:0060429 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 2.90e-03 | 59 | 28 | 2 | GO:0000381 | |
| GeneOntologyBiologicalProcess | negative regulation of cell growth | 2.90e-03 | 212 | 28 | 3 | GO:0030308 | |
| GeneOntologyBiologicalProcess | heart development | 3.20e-03 | 757 | 28 | 5 | GO:0007507 | |
| GeneOntologyBiologicalProcess | viral process | 3.37e-03 | 464 | 28 | 4 | GO:0016032 | |
| GeneOntologyCellularComponent | hemidesmosome | 9.45e-05 | 11 | 28 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.30e-04 | 269 | 28 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 5.49e-04 | 287 | 28 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | calyx of Held | 1.06e-03 | 36 | 28 | 2 | GO:0044305 | |
| MousePheno | small pancreatic islets | 6.43e-05 | 46 | 24 | 3 | MP:0009172 | |
| MousePheno | decreased susceptibility to Ortervirales infection | 1.85e-04 | 12 | 24 | 2 | MP:0020920 | |
| MousePheno | increased susceptibility to Retroviridae infection | 1.85e-04 | 12 | 24 | 2 | MP:0020934 | |
| MousePheno | decreased susceptibility to Retroviridae infection | 1.85e-04 | 12 | 24 | 2 | MP:0020935 | |
| MousePheno | increased susceptibility to Ortervirales infection | 2.18e-04 | 13 | 24 | 2 | MP:0020919 | |
| Domain | RRM | 2.50e-08 | 217 | 28 | 7 | SM00360 | |
| Domain | RRM_dom | 3.40e-08 | 227 | 28 | 7 | IPR000504 | |
| Domain | RRM | 3.72e-08 | 230 | 28 | 7 | PS50102 | |
| Domain | - | 5.58e-08 | 244 | 28 | 7 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 8.18e-08 | 258 | 28 | 7 | IPR012677 | |
| Domain | - | 3.24e-05 | 6 | 28 | 2 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 4.53e-05 | 7 | 28 | 2 | IPR001101 | |
| Domain | Plectin | 4.53e-05 | 7 | 28 | 2 | PF00681 | |
| Domain | PLEC | 4.53e-05 | 7 | 28 | 2 | SM00250 | |
| Domain | K_chnl_volt-dep_Kv1 | 6.03e-05 | 8 | 28 | 2 | IPR003972 | |
| Domain | - | 1.18e-04 | 11 | 28 | 2 | 3.40.50.800 | |
| Domain | APOBEC_N | 1.42e-04 | 12 | 28 | 2 | PF08210 | |
| Domain | Znf_C2H2_matrin | 1.42e-04 | 12 | 28 | 2 | IPR000690 | |
| Domain | APOBEC_N | 1.42e-04 | 12 | 28 | 2 | IPR013158 | |
| Domain | Anticodon-bd | 1.95e-04 | 14 | 28 | 2 | IPR004154 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.95e-04 | 14 | 28 | 2 | IPR016192 | |
| Domain | RRM_1 | 2.48e-04 | 208 | 28 | 4 | PF00076 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 2.91e-04 | 17 | 28 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 2.91e-04 | 17 | 28 | 2 | IPR002125 | |
| Domain | Cytidine_deaminase-like | 2.91e-04 | 17 | 28 | 2 | IPR016193 | |
| Domain | ZF_MATRIN | 3.27e-04 | 18 | 28 | 2 | PS50171 | |
| Domain | G_patch | 5.38e-04 | 23 | 28 | 2 | SM00443 | |
| Domain | G_patch_dom | 5.38e-04 | 23 | 28 | 2 | IPR000467 | |
| Domain | G-patch | 5.38e-04 | 23 | 28 | 2 | PF01585 | |
| Domain | G_PATCH | 5.38e-04 | 23 | 28 | 2 | PS50174 | |
| Domain | zf-CCHC | 5.38e-04 | 23 | 28 | 2 | PF00098 | |
| Domain | - | 6.89e-04 | 26 | 28 | 2 | 4.10.60.10 | |
| Domain | K_chnl_volt-dep_Kv | 7.43e-04 | 27 | 28 | 2 | IPR003968 | |
| Domain | ZnF_U1 | 8.58e-04 | 29 | 28 | 2 | SM00451 | |
| Domain | Znf_U1 | 8.58e-04 | 29 | 28 | 2 | IPR003604 | |
| Domain | VG_K_chnl | 1.11e-03 | 33 | 28 | 2 | IPR028325 | |
| Domain | ZF_CCHC | 1.25e-03 | 35 | 28 | 2 | PS50158 | |
| Domain | BTB_2 | 2.85e-03 | 53 | 28 | 2 | PF02214 | |
| Domain | T1-type_BTB | 2.85e-03 | 53 | 28 | 2 | IPR003131 | |
| Domain | ZnF_C2HC | 3.06e-03 | 55 | 28 | 2 | SM00343 | |
| Domain | Znf_CCHC | 3.06e-03 | 55 | 28 | 2 | IPR001878 | |
| Domain | Channel_four-helix_dom | 3.29e-03 | 57 | 28 | 2 | IPR027359 | |
| Domain | - | 3.29e-03 | 57 | 28 | 2 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 1.26e-02 | 114 | 28 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.26e-02 | 114 | 28 | 2 | PF00520 | |
| Pathway | WP_MRNA_PROCESSING | 3.74e-05 | 451 | 21 | 6 | MM15946 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 4.42e-05 | 7 | 21 | 2 | MM15412 | |
| Pathway | REACTOME_MRNA_EDITING | 7.56e-05 | 9 | 21 | 2 | MM15445 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 1.15e-04 | 11 | 21 | 2 | MM1501 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 1.38e-04 | 12 | 21 | 2 | M7772 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 1.90e-04 | 14 | 21 | 2 | M668 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 1.90e-04 | 14 | 21 | 2 | MM1489 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 2.84e-04 | 17 | 21 | 2 | M111 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 2.84e-04 | 17 | 21 | 2 | MM1491 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 1.05e-03 | 137 | 21 | 3 | M145 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RBM6 APOBEC3B DROSHA BCLAF1 RBM4B RBM4 RBM10 MATR3 EIF4B NCOA5 | 1.17e-10 | 714 | 28 | 10 | 28302793 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RBM6 EPPK1 APOBEC3B DROSHA BCLAF1 RBM4B RBM4 MATR3 EIF4B NCOA5 | 3.85e-10 | 807 | 28 | 10 | 22681889 |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 4.71e-08 | 254 | 28 | 6 | 28431233 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 4.98e-08 | 989 | 28 | 9 | 36424410 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 5.17e-08 | 258 | 28 | 6 | 37794589 | |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 1.29e-07 | 57 | 28 | 4 | 17932509 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.13e-07 | 180 | 28 | 5 | 35198878 | |
| Pubmed | The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum. | 6.25e-07 | 2 | 28 | 2 | 18708123 | |
| Pubmed | Expression and chromosomal localization of a lymphocyte K+ channel gene. | 6.25e-07 | 2 | 28 | 2 | 2251283 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17499243 | ||
| Pubmed | Phylogenetic and molecular characterization of the splicing factor RBM4. | 6.25e-07 | 2 | 28 | 2 | 23527094 | |
| Pubmed | 6.63e-07 | 652 | 28 | 7 | 31180492 | ||
| Pubmed | 8.83e-07 | 222 | 28 | 5 | 35941108 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.01e-06 | 1024 | 28 | 8 | 24711643 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.53e-06 | 1082 | 28 | 8 | 38697112 | |
| Pubmed | 1.76e-06 | 109 | 28 | 4 | 29511296 | ||
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.87e-06 | 3 | 28 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.87e-06 | 3 | 28 | 2 | 27602762 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.87e-06 | 3 | 28 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.87e-06 | 3 | 28 | 2 | 24577894 | |
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.87e-06 | 3 | 28 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.87e-06 | 3 | 28 | 2 | 23533681 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11854008 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 1541833 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 27356895 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.87e-06 | 3 | 28 | 2 | 25589647 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.87e-06 | 3 | 28 | 2 | 31518043 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.87e-06 | 3 | 28 | 2 | 24840555 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 9765497 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24453360 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23449789 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.87e-06 | 3 | 28 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.87e-06 | 3 | 28 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.87e-06 | 3 | 28 | 2 | 18772436 | |
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.87e-06 | 3 | 28 | 2 | 18786991 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 286744 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24725948 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20702647 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20980520 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 284359 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20617165 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 1.87e-06 | 3 | 28 | 2 | 39208378 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 31943071 | ||
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.87e-06 | 3 | 28 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.87e-06 | 3 | 28 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.87e-06 | 3 | 28 | 2 | 25505062 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 31595054 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 27821480 | ||
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.87e-06 | 3 | 28 | 2 | 17967065 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20335265 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 12469345 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.87e-06 | 3 | 28 | 2 | 29593034 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 31830125 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.87e-06 | 3 | 28 | 2 | 21998583 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 1.87e-06 | 3 | 28 | 2 | 38115583 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 1.87e-06 | 3 | 28 | 2 | 35458563 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 22275865 | ||
| Pubmed | A novel splicing regulator shares a nuclear import pathway with SR proteins. | 1.87e-06 | 3 | 28 | 2 | 12628928 | |
| Pubmed | A family of three mouse potassium channel genes with intronless coding regions. | 1.87e-06 | 3 | 28 | 2 | 2305265 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 293683 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 19150103 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.87e-06 | 3 | 28 | 2 | 12466850 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.88e-06 | 477 | 28 | 6 | 31300519 | |
| Pubmed | 2.39e-06 | 272 | 28 | 5 | 31010829 | ||
| Pubmed | 2.48e-06 | 274 | 28 | 5 | 34244482 | ||
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 3.75e-06 | 4 | 28 | 2 | 18983852 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 3.75e-06 | 4 | 28 | 2 | 31400166 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 23725696 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21985787 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 3.75e-06 | 4 | 28 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 3.75e-06 | 4 | 28 | 2 | 26253512 | |
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 3.75e-06 | 4 | 28 | 2 | 17020885 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20375169 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21147467 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 16055735 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 24332178 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 3.75e-06 | 4 | 28 | 2 | 18572219 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 16378963 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 15231068 | ||
| Pubmed | Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s. | 3.75e-06 | 4 | 28 | 2 | 32893454 | |
| Pubmed | Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. | 3.75e-06 | 4 | 28 | 2 | 15269786 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 3.75e-06 | 4 | 28 | 2 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 3.75e-06 | 4 | 28 | 2 | 20363737 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 3.75e-06 | 4 | 28 | 2 | 29343743 | |
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 3.75e-06 | 4 | 28 | 2 | 15674295 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21873525 | ||
| Pubmed | KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels. | 3.75e-06 | 4 | 28 | 2 | 12944270 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 25501566 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 18702815 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20538015 | ||
| Pubmed | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | 3.75e-06 | 4 | 28 | 2 | 38049664 | |
| Pubmed | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | 3.75e-06 | 4 | 28 | 2 | 26846717 | |
| Pubmed | Vaccinia virus replication is not affected by APOBEC3 family members. | 3.75e-06 | 4 | 28 | 2 | 17052331 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 28415995 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 9223268 | ||
| Interaction | HNRNPA1 interactions | RBM6 EPPK1 KCNA3 PLEC APOBEC3B DROSHA BCLAF1 RBM20 RBM10 MATR3 EIF4B NCOA5 | 1.60e-09 | 945 | 28 | 12 | int:HNRNPA1 |
| Interaction | MIRLET7D interactions | 4.70e-09 | 101 | 28 | 6 | int:MIRLET7D | |
| Interaction | MIRLET7G interactions | 1.14e-08 | 117 | 28 | 6 | int:MIRLET7G | |
| Interaction | PPP1CB interactions | 1.67e-07 | 469 | 28 | 8 | int:PPP1CB | |
| Interaction | MIR21 interactions | 2.10e-07 | 97 | 28 | 5 | int:MIR21 | |
| Interaction | MIRLET7I interactions | 4.70e-07 | 114 | 28 | 5 | int:MIRLET7I | |
| Interaction | RBM39 interactions | RBM6 APOBEC3B DROSHA BCLAF1 RBM4B RBM4 RBM10 MATR3 EIF4B NCOA5 | 7.31e-07 | 1042 | 28 | 10 | int:RBM39 |
| Interaction | MATR3 interactions | 2.08e-06 | 655 | 28 | 8 | int:MATR3 | |
| Interaction | OBSL1 interactions | 2.22e-06 | 902 | 28 | 9 | int:OBSL1 | |
| Interaction | SLTM interactions | 2.22e-06 | 156 | 28 | 5 | int:SLTM | |
| Interaction | CELF1 interactions | 2.34e-06 | 288 | 28 | 6 | int:CELF1 | |
| Interaction | SF1 interactions | 3.19e-06 | 304 | 28 | 6 | int:SF1 | |
| Interaction | MIR9-2 interactions | 3.76e-06 | 77 | 28 | 4 | int:MIR9-2 | |
| Interaction | ERCC6L interactions | 5.08e-06 | 83 | 28 | 4 | int:ERCC6L | |
| Interaction | SNW1 interactions | 5.52e-06 | 747 | 28 | 8 | int:SNW1 | |
| Interaction | RTN4 interactions | 6.18e-06 | 341 | 28 | 6 | int:RTN4 | |
| Interaction | MIR128-1 interactions | 7.66e-06 | 92 | 28 | 4 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 7.99e-06 | 93 | 28 | 4 | int:MIR214 | |
| Interaction | MIRLET7C interactions | 9.45e-06 | 97 | 28 | 4 | int:MIRLET7C | |
| Interaction | DDX5 interactions | 9.63e-06 | 568 | 28 | 7 | int:DDX5 | |
| Interaction | MIRLET7B interactions | 1.11e-05 | 101 | 28 | 4 | int:MIRLET7B | |
| Interaction | CMTR1 interactions | 1.14e-05 | 218 | 28 | 5 | int:CMTR1 | |
| Interaction | MIRLET7A3 interactions | 1.15e-05 | 102 | 28 | 4 | int:MIRLET7A3 | |
| Interaction | PKP2 interactions | 1.32e-05 | 225 | 28 | 5 | int:PKP2 | |
| Interaction | MIRLET7E interactions | 1.34e-05 | 106 | 28 | 4 | int:MIRLET7E | |
| Interaction | CUL7 interactions | 1.36e-05 | 845 | 28 | 8 | int:CUL7 | |
| Interaction | MIRLET7A1 interactions | 1.45e-05 | 108 | 28 | 4 | int:MIRLET7A1 | |
| Interaction | HNRNPK interactions | 1.46e-05 | 853 | 28 | 8 | int:HNRNPK | |
| Interaction | RPL5 interactions | 1.47e-05 | 606 | 28 | 7 | int:RPL5 | |
| Interaction | CDC5L interactions | 1.48e-05 | 855 | 28 | 8 | int:CDC5L | |
| Interaction | MIR34B interactions | 1.56e-05 | 110 | 28 | 4 | int:MIR34B | |
| Interaction | ZC3H18 interactions | 1.78e-05 | 877 | 28 | 8 | int:ZC3H18 | |
| Interaction | SAFB interactions | 1.95e-05 | 244 | 28 | 5 | int:SAFB | |
| Interaction | PAPOLG interactions | 1.96e-05 | 38 | 28 | 3 | int:PAPOLG | |
| Interaction | PDS5A interactions | 1.99e-05 | 245 | 28 | 5 | int:PDS5A | |
| Interaction | DHX40 interactions | 2.15e-05 | 249 | 28 | 5 | int:DHX40 | |
| Interaction | LATS1 interactions | 2.62e-05 | 440 | 28 | 6 | int:LATS1 | |
| Interaction | SNRPC interactions | 2.62e-05 | 440 | 28 | 6 | int:SNRPC | |
| Interaction | THRAP3 interactions | 2.72e-05 | 443 | 28 | 6 | int:THRAP3 | |
| Interaction | CCDC62 interactions | 2.78e-05 | 6 | 28 | 2 | int:CCDC62 | |
| Interaction | APOBEC3B interactions | 3.00e-05 | 130 | 28 | 4 | int:APOBEC3B | |
| Interaction | TOP1 interactions | 3.57e-05 | 696 | 28 | 7 | int:TOP1 | |
| Interaction | LARP1 interactions | 3.58e-05 | 465 | 28 | 6 | int:LARP1 | |
| Interaction | PABPC5 interactions | 4.24e-05 | 142 | 28 | 4 | int:PABPC5 | |
| Interaction | SNRPA interactions | 4.37e-05 | 482 | 28 | 6 | int:SNRPA | |
| Interaction | DNTTIP2 interactions | 4.48e-05 | 144 | 28 | 4 | int:DNTTIP2 | |
| Interaction | GLDC interactions | 7.23e-05 | 321 | 28 | 5 | int:GLDC | |
| Interaction | BCLAF1 interactions | 7.89e-05 | 327 | 28 | 5 | int:BCLAF1 | |
| Interaction | DTX2 interactions | 8.24e-05 | 330 | 28 | 5 | int:DTX2 | |
| Interaction | PPL interactions | 9.14e-05 | 173 | 28 | 4 | int:PPL | |
| Interaction | RRBP1 interactions | 9.61e-05 | 341 | 28 | 5 | int:RRBP1 | |
| Interaction | RBM12B interactions | 1.18e-04 | 69 | 28 | 3 | int:RBM12B | |
| Interaction | MIR9-3 interactions | 1.24e-04 | 70 | 28 | 3 | int:MIR9-3 | |
| Interaction | PTBP2 interactions | 1.34e-04 | 72 | 28 | 3 | int:PTBP2 | |
| Interaction | POP4 interactions | 1.34e-04 | 72 | 28 | 3 | int:POP4 | |
| Interaction | B9D2 interactions | 1.40e-04 | 73 | 28 | 3 | int:B9D2 | |
| Interaction | MIR29B1 interactions | 1.40e-04 | 73 | 28 | 3 | int:MIR29B1 | |
| Interaction | CLK2 interactions | 1.45e-04 | 195 | 28 | 4 | int:CLK2 | |
| Interaction | MIR20A interactions | 1.46e-04 | 74 | 28 | 3 | int:MIR20A | |
| Interaction | AATF interactions | 1.52e-04 | 376 | 28 | 5 | int:AATF | |
| Interaction | MIR429 interactions | 1.58e-04 | 76 | 28 | 3 | int:MIR429 | |
| Interaction | MIR200A interactions | 1.64e-04 | 77 | 28 | 3 | int:MIR200A | |
| Interaction | MIR451A interactions | 1.70e-04 | 78 | 28 | 3 | int:MIR451A | |
| Interaction | MIR222 interactions | 1.77e-04 | 79 | 28 | 3 | int:MIR222 | |
| Interaction | MIR1-2 interactions | 1.77e-04 | 79 | 28 | 3 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 1.77e-04 | 79 | 28 | 3 | int:MIR34C | |
| Interaction | MIR143 interactions | 1.84e-04 | 80 | 28 | 3 | int:MIR143 | |
| Interaction | MIR145 interactions | 1.91e-04 | 81 | 28 | 3 | int:MIR145 | |
| Interaction | RP1 interactions | 1.93e-04 | 15 | 28 | 2 | int:RP1 | |
| Interaction | PAN2 interactions | 1.96e-04 | 397 | 28 | 5 | int:PAN2 | |
| Interaction | HNRNPC interactions | 1.97e-04 | 634 | 28 | 6 | int:HNRNPC | |
| Interaction | MIR10B interactions | 1.98e-04 | 82 | 28 | 3 | int:MIR10B | |
| Interaction | SNRNP40 interactions | 2.03e-04 | 637 | 28 | 6 | int:SNRNP40 | |
| Interaction | MIR106A interactions | 2.05e-04 | 83 | 28 | 3 | int:MIR106A | |
| Interaction | MIR31 interactions | 2.12e-04 | 84 | 28 | 3 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 2.12e-04 | 84 | 28 | 3 | int:MIR7-2 | |
| Interaction | MIR200B interactions | 2.12e-04 | 84 | 28 | 3 | int:MIR200B | |
| Interaction | PRMT1 interactions | 2.18e-04 | 929 | 28 | 7 | int:PRMT1 | |
| Interaction | MIR17 interactions | 2.20e-04 | 85 | 28 | 3 | int:MIR17 | |
| Interaction | MIR93 interactions | 2.20e-04 | 85 | 28 | 3 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 2.20e-04 | 85 | 28 | 3 | int:MIR9-1 | |
| Interaction | MIR16-2 interactions | 2.20e-04 | 85 | 28 | 3 | int:MIR16-2 | |
| Interaction | MIR20B interactions | 2.28e-04 | 86 | 28 | 3 | int:MIR20B | |
| Interaction | MIR29A interactions | 2.35e-04 | 87 | 28 | 3 | int:MIR29A | |
| Interaction | MIR141 interactions | 2.44e-04 | 88 | 28 | 3 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 2.44e-04 | 88 | 28 | 3 | int:MIR138-2 | |
| Interaction | SRSF9 interactions | 2.47e-04 | 224 | 28 | 4 | int:SRSF9 | |
| Interaction | MIR29C interactions | 2.52e-04 | 89 | 28 | 3 | int:MIR29C | |
| Interaction | MIR221 interactions | 2.60e-04 | 90 | 28 | 3 | int:MIR221 | |
| Interaction | MIR1-1 interactions | 2.60e-04 | 90 | 28 | 3 | int:MIR1-1 | |
| Interaction | RPS15 interactions | 2.62e-04 | 423 | 28 | 5 | int:RPS15 | |
| Interaction | NUP35 interactions | 2.65e-04 | 424 | 28 | 5 | int:NUP35 | |
| Interaction | MECP2 interactions | 2.66e-04 | 1287 | 28 | 8 | int:MECP2 | |
| Interaction | PCBP1 interactions | 2.68e-04 | 671 | 28 | 6 | int:PCBP1 | |
| Interaction | DDX17 interactions | 2.71e-04 | 426 | 28 | 5 | int:DDX17 | |
| Interaction | MIR155 interactions | 2.78e-04 | 92 | 28 | 3 | int:MIR155 | |
| Interaction | SPEF2 interactions | 2.81e-04 | 18 | 28 | 2 | int:SPEF2 | |
| Interaction | NLRP5 interactions | 2.81e-04 | 18 | 28 | 2 | int:NLRP5 | |
| Interaction | PINK1 interactions | 2.86e-04 | 679 | 28 | 6 | int:PINK1 | |
| Interaction | MIR205 interactions | 2.87e-04 | 93 | 28 | 3 | int:MIR205 | |
| Cytoband | 11q13 | 2.37e-03 | 118 | 28 | 2 | 11q13 | |
| Cytoband | 15q11.2 | 4.95e-03 | 172 | 28 | 2 | 15q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 7.35e-03 | 211 | 28 | 2 | chr1p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q11 | 7.75e-03 | 217 | 28 | 2 | chr15q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.42e-02 | 298 | 28 | 2 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.72e-02 | 330 | 28 | 2 | chr22q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.97e-02 | 355 | 28 | 2 | chr8q24 | |
| GeneFamily | RNA binding motif containing | 2.13e-07 | 213 | 23 | 6 | 725 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.31e-05 | 8 | 23 | 2 | 939 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 1.01e-04 | 12 | 23 | 2 | 406 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.20e-04 | 13 | 23 | 2 | 685 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 3.52e-04 | 22 | 23 | 2 | 579 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 4.56e-04 | 25 | 23 | 2 | 74 | |
| GeneFamily | Potassium voltage-gated channels | 1.17e-03 | 40 | 23 | 2 | 274 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.81e-02 | 163 | 23 | 2 | 590 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.20e-02 | 181 | 23 | 2 | 694 | |
| Coexpression | GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP | 5.72e-05 | 199 | 28 | 4 | M6940 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 5.72e-05 | 199 | 28 | 4 | M6987 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_DC_UP | 5.83e-05 | 200 | 28 | 4 | M4490 | |
| Drug | AC1Q1NVI | 4.06e-06 | 3 | 27 | 2 | CID006439529 | |
| Drug | Flucytosine | 8.11e-06 | 4 | 27 | 2 | ctd:D005437 | |
| Drug | 5,8-diethoxypsoralen | 1.35e-05 | 5 | 27 | 2 | CID000656729 | |
| Drug | pyrimidin-2-one beta-ribofuranoside | 2.48e-05 | 48 | 27 | 3 | ctd:C009131 | |
| Disease | electrocardiography | 4.32e-06 | 530 | 25 | 6 | EFO_0004327 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.59e-04 | 125 | 25 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.59e-04 | 125 | 25 | 3 | C1879321 | |
| Disease | Head Neoplasms | 1.88e-04 | 24 | 25 | 2 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 1.88e-04 | 24 | 25 | 2 | C0887900 | |
| Disease | Cancer of Head | 1.88e-04 | 24 | 25 | 2 | C0751177 | |
| Disease | Cancer of Neck | 2.04e-04 | 25 | 25 | 2 | C0746787 | |
| Disease | Neck Neoplasms | 2.04e-04 | 25 | 25 | 2 | C0027533 | |
| Disease | osteoarthritis, knee | 3.18e-04 | 158 | 25 | 3 | EFO_0004616 | |
| Disease | body mass index, fasting blood insulin measurement | 3.58e-04 | 33 | 25 | 2 | EFO_0004340, EFO_0004466 | |
| Disease | Head and Neck Neoplasms | 3.58e-04 | 33 | 25 | 2 | C0018671 | |
| Disease | Leukemia, Myelocytic, Acute | 4.14e-04 | 173 | 25 | 3 | C0023467 | |
| Disease | Malignant Head and Neck Neoplasm | 6.38e-04 | 44 | 25 | 2 | C0278996 | |
| Disease | Male sterility | 7.59e-04 | 48 | 25 | 2 | C0917731 | |
| Disease | Male infertility | 7.59e-04 | 48 | 25 | 2 | C0021364 | |
| Disease | Subfertility, Male | 7.59e-04 | 48 | 25 | 2 | C0848676 | |
| Disease | multiple sclerosis | 1.47e-03 | 594 | 25 | 4 | MONDO_0005301 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.05e-03 | 301 | 25 | 3 | DOID:684 (is_marker_for) | |
| Disease | mean fractional anisotropy measurement | 2.93e-03 | 95 | 25 | 2 | EFO_0008399 | |
| Disease | Acute Confusional Senile Dementia | 3.18e-03 | 99 | 25 | 2 | C0546126 | |
| Disease | Presenile dementia | 3.18e-03 | 99 | 25 | 2 | C0011265 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNPMERMYRDTFYDN | 6 | Q96AK3 | |
| RNPMERMYRDTFYDN | 6 | Q9UH17 | |
| SRDHDYRDMDYRSYP | 31 | P98175 | |
| QRERDMFREADRYGP | 616 | Q5T481 | |
| DMARYEREQYADRAR | 346 | Q9BWF3 | |
| YDDSAFMEPRYHVRR | 86 | H3BUK9 | |
| MRYFDPLRNEYFFDR | 66 | P16389 | |
| SGYYDRMDYEDDRLR | 211 | P43243 | |
| YGPRDRMRDRYDAFC | 226 | Q9GZV7 | |
| DAYYQSPETRLRFMR | 416 | O95671 | |
| VDARRRDNGSYFFRM | 106 | P20138 | |
| SRDFRDQRDPMYDRY | 96 | Q9HCD5 | |
| DQRDPMYDRYRDMRD | 101 | Q9HCD5 | |
| SRDPMYRREGSYDRY | 116 | Q9HCD5 | |
| YRREGSYDRYLRMDD | 121 | Q9HCD5 | |
| RMRYFDPLRNEYFFD | 136 | P22001 | |
| DMARYEREQYVDRAR | 341 | Q9BQ04 | |
| RMYSRDYRRDYRNNR | 51 | Q9NYF8 | |
| DYRRDYRNNRGMRRP | 56 | Q9NYF8 | |
| YRRDNPAMTRGRYRE | 156 | P12081 | |
| EYQTAYRFLEEMRRR | 1391 | Q96RY7 | |
| RRDMDRYGGRDRYDD | 246 | P23588 | |
| RQDTDYRSMEYRDVD | 396 | P78332 | |
| PDRRRQDSRYRSDYD | 256 | Q9NRR4 | |
| EQLNRYEMYRRSAFP | 116 | Q15544 | |
| YDDSAFMEPRYHVRR | 86 | A0A0A6YYL3 | |
| VDARYQRDYEEMASR | 301 | P29590 | |
| DVAYRRGYFDEEMNR | 3961 | P58107 | |
| YRRGYFDEEMNRVLA | 5031 | P58107 | |
| TFRDYQMRYRDNTPL | 1121 | Q96J65 | |
| GDDFSRRYRRDFAEM | 101 | P10415 | |
| RFRYDDGTFYPRNEM | 461 | Q70Z35 | |
| AYRRGYFDEEMNRVL | 2966 | Q15149 |